Pharmaceuticals company Jubilant Pharmova announced Q2FY25 & H1FY25 results Q2FY25 Financial Highlights: Total income grew by 5% on a YoY basis to Rs 1,774 crore. EBITDA grew by 19% on a YoY basis to Rs 311 crore. EBITDA margins improved by 210 basis points on YoY basis to 17.5%. PAT increased by 65% on a YoY basis to Rs 103 crore. Net debt/ EBITDA improved to 1.5x as on Sep’24 from 2.5x as on Mar’24. H1FY25 Financial Highlights: Total income grew by 7% on YoY basis to Rs 3,520 crore. EBITDA grew by 32% on YoY basis to Rs 577 crore. Profit after tax increased by 153% to Rs 172 crore. Result PDF